Clinical trial
Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00003709 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00003709 |
|---|---|
| Title | Chemotherapy in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I and Pharmacokinetic Study of FB-642 Administered Orally on a Weekly Schedule to Patients With Advanced Solid Tumors |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer Therapy and Research Center, Texas |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | carbendazim |
| Enrollment | 25 |
| Start date | Oct 1, 1998 |
| Primary completion | Nov 1, 2000 |
| Completion | Nov 1, 2000 |
| First posted | Aug 17, 2004 |
| Last update posted | Aug 9, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: